Technical Analysis for IBO - Impact BioMedical, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | N/A | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 1.89% | |
Inside Day | Range Contraction | 1.89% | |
Wide Bands | Range Expansion | 1.89% | |
20 DMA Support | Bullish | 7.57% | |
Slingshot Bullish | Bullish Swing Setup | 7.57% | |
Wide Bands | Range Expansion | 7.57% | |
Gapped Down | Weakness | 7.57% | |
New 52 Week Closing High | Bullish | -11.19% | |
Pocket Pivot | Bullish Swing Setup | -11.19% | |
Spinning Top | Other | -11.19% |
Alert | Time |
---|---|
20 DMA Support | about 2 hours ago |
10 DMA Resistance | about 2 hours ago |
Down 5% | about 2 hours ago |
Down 3% | about 2 hours ago |
Up 5% | about 2 hours ago |
Get a Trading Sidekick!
- Earnings date: Unknown
Impact BioMedical, Inc. Description
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, it develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. The company was incorporated in 2018 and is based in Houston, Texas.
Classification
Sector: Healthcare
Industry: Biotechnology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.2499 |
52 Week Low | 1.22 |
Average Volume | 98,423 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 0.00 |
20-Day Moving Average | 2.54 |
10-Day Moving Average | 2.77 |
Average True Range | 0.40 |
RSI (14) | 54.55 |
ADX | 31.9 |
+DI | 20.63 |
-DI | 17.29 |
Chandelier Exit (Long, 3 ATRs) | 2.05 |
Chandelier Exit (Short, 3 ATRs) | 2.45 |
Upper Bollinger Bands | 3.23 |
Lower Bollinger Band | 1.85 |
Percent B (%b) | 0.58 |
BandWidth | 54.11 |
MACD Line | 0.20 |
MACD Signal Line | 0.20 |
MACD Histogram | 0.0007 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.34 | ||||
Resistance 3 (R3) | 3.33 | 3.10 | 3.23 | ||
Resistance 2 (R2) | 3.10 | 2.92 | 3.10 | 3.19 | |
Resistance 1 (R1) | 2.87 | 2.81 | 2.99 | 2.88 | 3.15 |
Pivot Point | 2.64 | 2.64 | 2.69 | 2.64 | 2.64 |
Support 1 (S1) | 2.41 | 2.46 | 2.53 | 2.42 | 2.15 |
Support 2 (S2) | 2.18 | 2.35 | 2.18 | 2.11 | |
Support 3 (S3) | 1.95 | 2.18 | 2.08 | ||
Support 4 (S4) | 1.96 |